Posted on September 9, 2024 Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine) Read More
Posted on December 7, 2018 GLATECTTM IS NOW COVERED BY THE PROVINCIAL DRUG PLAN IN BRITISH COLUMBIA FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS). Read More